alpha-aminopyridine has been researched along with Spinal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, H; Barth, TF; Böhm, M; Brüderlein, S; Flanagan, AM; Goerttler, LT; Kornmann, M; Lechel, A; Marienfeld, R; Mayer-Steinacker, R; Mellert, K; Möller, P; Schultheiss, M; von Baer, A; von Witzleben, A | 1 |
1 other study(ies) available for alpha-aminopyridine and Spinal Neoplasms
| Article | Year |
|---|---|
Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminopyridines; Benzimidazoles; Cell Cycle; Cell Line, Tumor; Chordoma; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Screening Assays, Antitumor; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, p16; Humans; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Proteins; Piperazines; Protein Kinase Inhibitors; Pyridines; RNA, Messenger; RNA, Neoplasm; Sacrum; Spinal Neoplasms; Young Adult | 2015 |